I have raised this question before but here goes a
Post# of 36536
What is Generex role in this agreement?
What role does Generex playin the development, marketing or distribution of a vaccine?
NGIO is a wholly owned subsidiary, why is GNBT 8King this?
If the answers are none, none and I don’t know then there is no reason GNBT should get a bump on the news.
If however GNBT is brokering the deal and will collect direct commissions or royalties I’d like to know that and it should probably be public info.